Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Update

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 8,600 shares, an increase of 109.8% from the December 15th total of 4,100 shares. Based on an average trading volume of 27,900 shares, the days-to-cover ratio is currently 0.3 days.

Bavarian Nordic A/S Stock Performance

OTCMKTS:BVNRY opened at $8.84 on Tuesday. The company has a market capitalization of $2.09 billion, a PE ratio of 12.81 and a beta of 1.65. Bavarian Nordic A/S has a fifty-two week low of $6.86 and a fifty-two week high of $14.60. The company has a 50 day simple moving average of $9.09 and a two-hundred day simple moving average of $10.10.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.